Estradiol, an estrogen receptor-alpha ligand, was found to increase adenosine A1 receptor expression in a breast cancer cell line, suggesting that estrogen receptor activation can modulate adenosine receptor expression and activity [5]. The gene discussed is ESR1; the disease is breast carcinoma.